Fig. 3From: Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United StatesOutpatient resource use for AE management among subset of patients with ≥1 AE. Abbreviations: AE, adverse event; ARI, androgen receptor inhibitorBack to article page